المتابع اليومي
عضو نشط
- التسجيل
- 11 يوليو 2003
- المشاركات
- 216
ptie
About Pain Therapeutics, Inc.
We are a biopharmaceutical company specializing in the development of novel painkillers. We believe our unique insights into the biology and biochemistry of pain allow us to develop new drug candidates that address unmet clinical needs in pain management. We have two drug candidates in Phase III clinical trials: Oxytrex(TM) for chronic pain and PTI-901 for patients with Irritable Bowel Syndrome. Our third drug candidate, Remoxy(TM), is an abuse resistant, long-acting oxycodone.
For more information please visit our website at www.paintrials.com.
news
Press Release Source: Pain Therapeutics, Inc.,
Pain Therapeutics Announces Significant Expansion of Its Intellectual Property
Friday February 27, 8:00 am ET
Over 60 Intellectual Property Filings Held by Company
SOUTH SAN FRANCISCO, Calif., Feb. 27 /PRNewswire-FirstCall/ -- Pain Therapeutics, Inc., (Nasdaq: PTIE - News), a biopharmaceutical company, today announced a significant expansion of its intellectual property. The Company now holds over 60 intellectual property filings in the United States or abroad, nearly double its previous holdings of 31 such filings.
الخبر جيد والتحليل يبين ان هناك دعم متوسط 200 وفيبوناسي نازل 61.8 الهدف الاول 7.5 الثاني 8.5 الثالث 9
للمتابعة والشراء عند التاكد من الارتداد من متوسط 200
مع هذا الخبر فرصة الصعود اكبر
اما اذا كسرت متوسط 200 فنزول الى نقاط الدعم التالية
6.5 , 6 ,5 ,4.5
وبالتوفيق
About Pain Therapeutics, Inc.
We are a biopharmaceutical company specializing in the development of novel painkillers. We believe our unique insights into the biology and biochemistry of pain allow us to develop new drug candidates that address unmet clinical needs in pain management. We have two drug candidates in Phase III clinical trials: Oxytrex(TM) for chronic pain and PTI-901 for patients with Irritable Bowel Syndrome. Our third drug candidate, Remoxy(TM), is an abuse resistant, long-acting oxycodone.
For more information please visit our website at www.paintrials.com.
news
Press Release Source: Pain Therapeutics, Inc.,
Pain Therapeutics Announces Significant Expansion of Its Intellectual Property
Friday February 27, 8:00 am ET
Over 60 Intellectual Property Filings Held by Company
SOUTH SAN FRANCISCO, Calif., Feb. 27 /PRNewswire-FirstCall/ -- Pain Therapeutics, Inc., (Nasdaq: PTIE - News), a biopharmaceutical company, today announced a significant expansion of its intellectual property. The Company now holds over 60 intellectual property filings in the United States or abroad, nearly double its previous holdings of 31 such filings.
الخبر جيد والتحليل يبين ان هناك دعم متوسط 200 وفيبوناسي نازل 61.8 الهدف الاول 7.5 الثاني 8.5 الثالث 9
للمتابعة والشراء عند التاكد من الارتداد من متوسط 200
مع هذا الخبر فرصة الصعود اكبر
اما اذا كسرت متوسط 200 فنزول الى نقاط الدعم التالية
6.5 , 6 ,5 ,4.5
وبالتوفيق
